| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/18/1995 | US5407579 Hemoglobin purification |
| 04/18/1995 | US5407546 Method for high-resolution two-dimensional electrophoresis and device for carrying out the same |
| 04/18/1995 | US5407454 Larvicidal lectins and plant insect resistance based thereon |
| 04/18/1995 | CA1335320C Sequential polypeptides endowed with immunological activity |
| 04/18/1995 | CA1335255C Low ph pharmaceutical compositions of recombinant beta-interferon |
| 04/16/1995 | CA2133271A1 Methods and compositions for the oral delivery of therapeutic agents |
| 04/16/1995 | CA2108606A1 X-linked adrenoleukodystrophy gene and corresponding protein |
| 04/13/1995 | WO1995009926A1 Genes encoding resistance to dna alkylating agents |
| 04/13/1995 | WO1995009924A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | WO1995009922A1 Cloned pullulanase |
| 04/13/1995 | WO1995009920A1 Virus resistant or tolerant cells |
| 04/13/1995 | WO1995009919A1 Vaccines and diagnostics for borrelia burgdorferi |
| 04/13/1995 | WO1995009918A1 Tissue inhibitor metalloproteinase type three (timp-3) |
| 04/13/1995 | WO1995009916A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 04/13/1995 | WO1995009914A1 Multicloning vector, expression vector, and production of foreign protein with expression vector |
| 04/13/1995 | WO1995009913A1 Human monocyte/macrophage derived metalloproteinase inhibitor |
| 04/13/1995 | WO1995009912A1 Stem cell proliferation factor |
| 04/13/1995 | WO1995009910A1 Gene that identifies sterile plant cytoplasm and process for preparing hybrid plant by using the same |
| 04/13/1995 | WO1995009873A1 A monoclonal anti-human il-6 receptor antibody |
| 04/13/1995 | WO1995009872A1 Dna encoding prostaglandin receptor ip |
| 04/13/1995 | WO1995009871A1 Novel antitumor peptide |
| 04/13/1995 | WO1995009870A1 Characterization of mycoplasma hyopneumoniae adhesins |
| 04/13/1995 | WO1995009869A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | WO1995009656A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | WO1995009655A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | WO1995009654A1 Gene therapy of the nervous system |
| 04/13/1995 | WO1995009649A1 Vaccine compositions |
| 04/13/1995 | WO1995009643A1 Endothelin activity inhibitor |
| 04/13/1995 | WO1995009642A1 Method for provoking immunity by peptides labelled with a photoactivatable group which binds to mhc molecules |
| 04/13/1995 | WO1995007991A3 Subtilisin bpn' variants with decreased adsorption and increased hydrolysis |
| 04/13/1995 | WO1995007989A3 A disease resistance gene from maize and its use for disease resistance, as a selectable marker and as a gene identification probe |
| 04/13/1995 | WO1995006727A3 Uses of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune disease |
| 04/13/1995 | DE4333621A1 Use of calcitonin gene related peptides for the specific diagnosis of erectile dysfunctions |
| 04/13/1995 | CA2173598A1 Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same |
| 04/13/1995 | CA2173495A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 04/13/1995 | CA2173217A1 Novel receptor-type phosphotyrosine phosphatase-sigma |
| 04/13/1995 | CA2171109A1 Gene therapy of the nervous system |
| 04/13/1995 | CA2151261A1 Tia-1 binding proteins and isolated complementary dna encoding the same |
| 04/13/1995 | CA2133872A1 Molecules influencing the shedding of the tnf receptor, their preparation and their use |
| 04/12/1995 | EP0647849A2 Detecting the presence of analytes in a sample |
| 04/12/1995 | EP0647716A1 Vector comprising viral gene transcribed by ARN polymerase III |
| 04/12/1995 | EP0647711A1 Plants transformed with a DNA sequence from bacillus thuringiensis lethal to lepidoptera |
| 04/12/1995 | EP0647656A1 Motilin-like polypeptides that inhibit gastrointestinal motor activity |
| 04/12/1995 | EP0647655A1 Synthetic peptides and vaccines against parvovirus |
| 04/12/1995 | EP0647449A1 Sustained-release preparation of anti-endothelin substance |
| 04/12/1995 | EP0647444A1 L-2-oxothiazolidine-4-carboxylate and other stimulators of intracellular glutathione synthesis for reducing or preventing bone marrow hypoplasia |
| 04/12/1995 | EP0647408A1 Protein isolate having an increased level of isoflavone compounds and process for producing the same |
| 04/12/1995 | EP0647395A2 Mice deficient in neurotrophin receptors |
| 04/12/1995 | EP0647277A1 Methods for using cks fusion proteins |
| 04/12/1995 | EP0647276A1 Protein preparations |
| 04/12/1995 | EP0647275A1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 04/12/1995 | EP0647274A1 Recombinant baculoviruses containing insect cellular promoter |
| 04/12/1995 | EP0647273A1 Dna sequences encoding oligosaccharide transporter |
| 04/12/1995 | EP0647272A1 Anti-hiv proteins gap 31, dap 30 and dap 32, dna coding therefor and therapeutic uses thereof |
| 04/12/1995 | EP0647271A1 Gene for ataxia-telangiectasia complementation group d (atdc) |
| 04/12/1995 | EP0647270A1 Novel malignant cell type markers of the interior nuclear matrix |
| 04/12/1995 | EP0647268A1 Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
| 04/12/1995 | EP0647239A1 Angiotensin iv peptides and receptor |
| 04/12/1995 | EP0647238A1 INTERLEUKIN-1$g(b) DELETION MUTANT |
| 04/12/1995 | EP0647236A1 Endothelin antagonists ii |
| 04/12/1995 | EP0647232A1 Deproteinization with azlactone-functional supports |
| 04/12/1995 | EP0647140A1 Papillomavirus vaccines |
| 04/12/1995 | EP0647139A1 ADHESIN-OLIGOSACCHARIDE CONJUGATE VACCINE FOR $i(HAEMOPHILUS INFLUENZAE) |
| 04/12/1995 | EP0567554B1 Method for the purification of intact, correctly-folded insulin-like growth factor-1 |
| 04/12/1995 | EP0526472B1 Household general-purpose adhesive on a polyurethane basis |
| 04/12/1995 | EP0478797B1 Novel physiologically active peptide originating in hog |
| 04/12/1995 | EP0478696B1 Efficient method for identifiable expression of non-selectable genes |
| 04/12/1995 | EP0429587B1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5 |
| 04/12/1995 | EP0383764B1 Bovine granulocyte-macrophage colony stimulating factor |
| 04/11/1995 | US5405952 DNA sequence encoding nonglycosylated analogs of human colony stimulating factors |
| 04/11/1995 | US5405946 Anticoagulants |
| 04/11/1995 | US5405945 DNA encoding reproductive hormones and expression using a minigene |
| 04/11/1995 | US5405942 Prepro insulin-like growth factors I and II |
| 04/11/1995 | US5405940 Isolated nonapeptides derived from MAGE genes and uses thereof |
| 04/11/1995 | US5405832 Method of treating non-streptococcal bacterial infections |
| 04/11/1995 | US5405785 Derivatives of cyclosporine A, antibodies directed thereto and uses thereof |
| 04/11/1995 | US5405783 Removing photoremovable protective group from region of substrate, contacting with protected amino acid, repeating to form peptide |
| 04/11/1995 | US5405777 Acetic acid assimilating gene and a method for preventing accumulation of acetic acid in culture medium |
| 04/11/1995 | US5405776 Genetic engineering |
| 04/11/1995 | US5405758 DNA encoding the recombinant 40 kDA Dermatophagoides farinae allergen |
| 04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
| 04/11/1995 | US5405754 Culturing; centrifuging; pelletization; suspension; heat treatment; enzyme-linked immunosorbent assay |
| 04/11/1995 | US5405750 Detection and measurement of cellular complex between antibody and growth factor receptor, for diagnosis of immune system disorders |
| 04/11/1995 | US5405749 Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen |
| 04/11/1995 | US5405748 Purification of the Gal/GalNAc lectin from a nonpathogenic form of the parasite |
| 04/11/1995 | US5405607 Method for preparing fibrinogen adhesive from whole blood |
| 04/11/1995 | CA1335227C Crf analog conjugates |
| 04/11/1995 | CA1335182C Cellulose binding fusion proteins |
| 04/11/1995 | CA1335180C Anti-thrombin-binding substance monoclonal antibodies, hybridomas producing same, as well as purification process and assay of thrombin-binding substance making use of said monoclonal antibodies |
| 04/11/1995 | CA1335177C Inductive collagen-based bone repair preparation |
| 04/06/1995 | WO1995009365A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 04/06/1995 | WO1995009249A1 Oral vaccination of mammals |
| 04/06/1995 | WO1995009241A2 Anti-cancer gene therapy by modulation of immune or inflammatory response |
| 04/06/1995 | WO1995009240A1 Receptor-activated reporter systems |
| 04/06/1995 | WO1995009239A2 Production, purification, cleavage and use of fusion peptides |
| 04/06/1995 | WO1995009237A2 Expression of human d4 dopamine receptors in stable cell lines |
| 04/06/1995 | WO1995009232A2 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their cns carrier, antibodies thereto, and uses thereof |
| 04/06/1995 | WO1995009185A1 Novel peptide, active as inhibitors of platelet aggregation |
| 04/06/1995 | WO1995009184A1 Use of relaxin as an analgesic and palliative for intractable pain |